First Look: DexCom Opens Data Platform, Launches Dev Program to Fuel Diabetes App Innovation

MHW can now confirm that DexCom, Inc. — a powerhouse in continuous glucose monitoring (CGM) — is making available a public API empowering third-party developers to connect patient-authorized CGM data into a broad range of software applications.

According to the official word, this “pioneering approach to CGM data sharing is intended to enable a rich ecosystem of novel solutions and put the user in control of where and how they interact with their glucose data.”

“In launching this developer platform, Dexcom combines our CGM data expertise with the creativity of the developer ecosystem to enable new solutions and business models in the treatment and management of diabetes,” said Annika Jimenez, Senior Vice President of Data, Dexcom. “Dexcom believes in data mobility and customer choice. It also believes that the API opens up opportunities to drive Dexcom CGM data into the heart of new digital solutions for payers, providers, and most importantly people with diabetes.”

Continuous glucose monitoring allows people with diabetes to continuously track their blood glucose levels in real-time. Dexcom CGM systems provide dynamic glucose information every five minutes, which creates a continuous stream of glucose data that can be invaluable for individual and population diabetes management. The Dexcom API allows Dexcom to ensure CGM data collaboration is secure, patient-privacy-centric, and FDA-compliant, while supporting a broad variety of new solutions and business models.

As of today, developers in the US can register here.

This post was written by:

- who has written 626 posts on mHealthWatch.

Contact the author